Back to Journals » OncoTargets and Therapy » Volume 9

Review

The evolution of combined molecular targeted therapies to advance the therapeutic efficacy in melanoma: a highlight of vemurafenib and cobimetinib

       
Total article views   HTML views PDF downloads Totals
8,712 Dovepress* 7,487+ 1,374 8,861
PubMed Central* 1,225 478 1,703
Totals 8,712 1,852 10,564
*Since 22 June 2016
+Since July 2016

View citations on PubMed Central and Google Scholar